Page last updated: 2024-09-03
tak 044 and hydralazine
tak 044 has been researched along with hydralazine in 1 studies
Compound Research Comparison
| Studies (tak 044) | Trials (tak 044) | Recent Studies (post-2010) (tak 044) | Studies (hydralazine) | Trials (hydralazine) | Recent Studies (post-2010) (hydralazine) |
|---|---|---|---|---|---|
| 105 | 8 | 2 | 4,580 | 364 | 393 |
Protein Interaction Comparison
| Protein | Taxonomy | tak 044 (IC50) | hydralazine (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 1.265 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.649 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kano, H; Kohno, M; Minami, M; Tatsumi, Y; Ueda, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
Other Studies
1 other study(ies) available for tak 044 and hydralazine
| Article | Year |
|---|---|
Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Hydralazine; Hypertension, Malignant; Kidney; Male; Myocardium; Organ Size; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Reference Values; Sodium Chloride | 1997 |